|
시장보고서
상품코드
2055145
흉곽 출구 증후군 시장 : 유형별, 치료 기기 유형별, 진단 기술별, 최종사용자별, 환자층별, 유통 채널별, 지역별Thoracic Outlet Syndrome Market, By Type, By Treatment Device Type, By Diagnosis Technology, By End User, By Patient Group, By Distribution Channel, By Geography |
||||||
흉곽 출구 증후군 시장은 2026년에 2억 4,880만 달러로 추정되며, 2033년까지 3억 7,660만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 6.1%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 2억 4,880만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 6.10% | 2033년 시장 규모 예측 : | 3억 7,660만 달러 |
흉곽 출구 증후군(TOS)은 쇄골과 제1늑골 사이의 공간인 흉곽출구에서 신경이나 혈관이 압박, 손상 또는 자극을 받아 발생하는 복합적인 질환군을 말합니다. 이 질환은 팔 신경총의 신경에 영향을 미치는 신경성 TOS, 동맥 또는 정맥의 압박을 동반하는 혈관성 TOS, 그리고 명확한 신경학적 또는 혈관학적 소견을 동반하지 않는 만성 통증을 특징으로 하는 논란의 여지가 있는 TOS라는 세 가지 주요 유형으로 나타납니다. 전 세계 흉곽출구증후군 시장은 이 치료가 어려운 질환을 다루기 위해 고안된 종합적인 진단 도구, 치료법 및 수술용 기기를 아우르고 있습니다.
시장에는 정확한 진단을 위한 MRI 및 CT 혈관조영술과 같은 첨단 영상 진단 기술, 물리치료 기기 및 약물 요법을 포함한 비수술적 치료법, 그리고 제1늑골 절제술부터 사각근 절제술에 이르기까지 다양한 수술 기법에 대응하는 첨단 수술 기구가 포함되어 있습니다.
또한, 이 시장에는 보툴리눔툭신(보톡스) 주사나 저침습 수술 기술과 같은 새로운 치료 접근법도 포함되어 있습니다. 의료 종사자들의 인식 제고, 진단 능력 향상, 그리고 환자 권리 옹호 활동의 확대에 따라 TOS 시장은 지속적으로 발전하고 있습니다. 이는 환자의 삶의 질과 신체 기능에 중대한 영향을 미치면서도 종종 진단이 간과되기 쉬운 이 질환을 관리하기 위한 효과적인 해결책에 대한 필요성에 의해 주도되고 있습니다.
시장 역학
세계 흉곽 출구 증후군(TOS) 시장은 몇 가지 주요 요인의 견인 속에 견조한 성장세를 보이고 있으며, 이 질환에 대한 인식 제고와 진단 능력 향상이 시장 확대의 주요 원동력이 되고 있습니다. 특히 운동선수, 컴퓨터 사용자, 반복적인 부하가 따르는 직업에 종사하는 사람들의 TOS 유병률 증가와 더불어, 의료 종사자들의 증상 인식이 향상됨에 따라 시장 수요가 크게 증가하고 있습니다.
고해상도 MRI 및 동적 CT 혈관조영술을 포함한 영상 진단 기술의 발전은 검출 정확도를 높여 시장 성장을 견인하고 있습니다. 최소 침습 수술 기술, 보툴리눔툭신(보톡스)를 이용한 표적 치료, 첨단 물리치료법 등 혁신적인 치료 접근법의 개발은 막대한 시장 기회를 창출하고 있습니다.
그러나 시장 성장에는 일정한 제약도 존재합니다. 수근관 증후군이나 경부 신경근증 등 다른 질환과의 증상 중복으로 인한 오진 문제가 지적되고 있으며, 이로 인해 적절한 치료와 시장 침투가 지연될 가능성이 있습니다. TOS 진단은 복잡하기 때문에 대부분의 경우 전문 지식이 필요하지만, 모든 의료 현장에서 이러한 전문 지식을 쉽게 구할 수 있는 것은 아니어서 시장의 접근성을 제한하고 있습니다.
또한, 지역에 따라 치료 프로토콜이 다르며, 표준화된 진단 기준이 부재한 점도 시장 표준화를 위한 과제로 대두되고 있습니다. 그럼에도 불구하고, 의료 인프라에 대한 투자 확대, 스포츠 의학 및 산업 위생에 대한 관심 증가, 그리고 환자 중심의 치료 접근법에 대한 수요 증가로 인해 큰 기회가 창출되고 있습니다. 혈관성 TOS 발병 위험이 높은 고령 인구 증가 또한 성장의 한 축을 이루고 있습니다. 또한, 새로운 치료 표적에 대한 지속적인 연구 개발과 TOS의 아형에 기반한 맞춤형 치료 전략의 개발은 이 전문 의료 분야 시장 확대와 혁신에 유망한 전망을 제시하고 있습니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 매개변수를 바탕으로 전 세계 흉곽출구증후군 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로는 기업의 주요 정보, 제품 포트폴리오, 주요 성과, 재무 실적 및 전략입니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 세계의 흉곽출구증후군 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 흉곽출구증후군 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 흉곽 출구 증후군 시장 : 유형별, 2021년-2033년
제5장 세계의 흉곽 출구 증후군 시장 : 치료 기기 유형별, 2021년-2033년
제6장 세계의 흉곽 출구 증후군 시장 : 진단 기술별, 2021년-2033년
제7장 세계의 흉곽 출구 증후군 시장 : 최종사용자별, 2021년-2033년
제8장 세계의 흉곽 출구 증후군 시장 : 환자 그룹별, 2021년-2033년
제9장 세계의 흉곽 출구 증후군 시장 : 유통 채널별, 2021년-2033년
제10장 세계의 흉곽 출구 증후군 시장 : 지역별, 2021년-2033년
제11장 경쟁 구도
제12장 애널리스트의 제안
제13장 참고 문헌 및 조사 방법
LSH 26.06.22Thoracic Outlet Syndrome Market is estimated to be valued at USD 248.8 Mn in 2026 and is expected to reach USD 376.6 Mn by 2033, growing at a compound annual growth rate (CAGR) of 6.1% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 248.8 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.10% | 2033 Value Projection: | USD 376.6 Mn |
Thoracic Outlet Syndrome (TOS) represents a complex group of disorders resulting from compression, injury, or irritation of nerves and blood vessels in the thoracic outlet, the space between the collarbone and first rib. This condition manifests through three primary variants: neurogenic TOS affecting the brachial plexus nerves, vascular TOS involving arterial or venous compression, and disputed TOS characterized by chronic pain without clear neurological or vascular findings. The global Thoracic Outlet Syndrome market encompasses a comprehensive range of diagnostic tools, therapeutic interventions, and surgical devices designed to address this challenging condition.
Market offerings include advanced imaging technologies such as MRI and CT angiography for accurate diagnosis, conservative treatment modalities including physical therapy equipment and pharmacological interventions, and sophisticated surgical instruments for procedures ranging from first rib resection to scalenectomy.
The market also incorporates emerging treatment approaches such as botulinum toxin injections and minimally invasive surgical techniques. With increasing awareness among healthcare professionals, improved diagnostic capabilities, and growing patient advocacy, the TOS market continues to evolve, driven by the need for effective solutions to manage this often underdiagnosed condition that significantly impacts patients' quality of life and functional capacity.
Market Dynamics
The global thoracic outlet syndrome market experiences robust growth driven by several compelling factors, with increasing disease awareness and improved diagnostic capabilities serving as primary catalysts for market expansion. The rising prevalence of TOS, particularly among athletes, computer users, and individuals in repetitive strain occupations, coupled with better recognition of symptoms by healthcare providers, significantly drives market demand.
Technological advancements in diagnostic imaging, including high-resolution MRI and dynamic CT angiography, enhance detection accuracy and fuel market growth. The development of minimally invasive surgical techniques and innovative therapeutic approaches, such as targeted botulinum toxin treatments and advanced physical therapy modalities, creates substantial market opportunities.
However, market growth faces certain restraints, including the challenge of misdiagnosis due to symptom overlap with other conditions like carpal tunnel syndrome and cervical radiculopathy, which can delay appropriate treatment and market penetration. The complexity of TOS diagnosis often requires specialized expertise that may not be readily available in all healthcare settings, limiting market reach.
Additionally, varying treatment protocols and lack of standardized diagnostic criteria across different regions pose challenges for market standardization. Nevertheless, significant opportunities emerge from increasing investment in healthcare infrastructure, growing emphasis on sports medicine and occupational health, and rising demand for patient-centric treatment approaches. The expanding elderly population, who are more susceptible to vascular TOS, presents another growth avenue. Furthermore, ongoing research into novel therapeutic targets and the development of personalized treatment strategies based on TOS subtypes offer promising prospects for market expansion and innovation in this specialized healthcare segment.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global thoracic outlet syndrome market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Medtronic, Stryker, Boston Scientific, Becton Dickinson (BD), Zimmer Biomet, Smith and Nephew, Johnson and Johnson (DePuy Synthes), Philips Healthcare, Siemens Healthineers, GE HealthCare, Mindray, Canon Medical Systems, Fujifilm Healthcare, Terumo Corporation, and AngioDynamics
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global thoracic outlet syndrome market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global thoracic outlet syndrome market
Market Segmentation
- Type Insights (Revenue, USD Mn, 2021 - 2033)
- Neurogenic Thoracic Outlet Syndrome
- Venous Thoracic Outlet Syndrome
- Arterial Thoracic Outlet Syndrome
- Combined/Mixed TOS (neurogenic + vascular)
- Treatment Device Type Insights (Revenue, USD Mn, 2021 - 2033)
- Minimally Invasive Devices
- Catheters (Diagnostic and Interventional)
- Thrombectomy Devices
- Angioplasty Balloons
- Vascular Stents
- Others (Thrombolytic Delivery Systems)
- Surgical Devices
- Thoracoscopic Instruments (VATS Tools)
- Robotic-Assisted Surgical Systems
- Open Surgical Instruments (Resection Tools, Scalpels, Clamps)
- Others (Hemostatic and Sealing Devices)
- Supportive/Non-Surgical Treatment Devices
- Orthopedic Braces and Postural Correction Devices
- Physiotherapy and Rehabilitation Devices
- Others (Neuromodulation and Pain Management Devices)
- Diagnosis Technology Insights (Revenue, USD Mn, 2021 - 2033)
- Electrodiagnostic Systems (EMG and Nerve Conduction Devices)
- Ultrasound Systems
- CT Scan and CT Angiography Systems
- MRI and MR Angiography Systems
- X-ray and Digital Radiography Systems
- Vascular Doppler Systems
- End User Insights (Revenue, USD Mn, 2021 - 2033)
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Diagnostic Imaging Centers
- Rehabilitation and Physiotherapy Centers
- Patient Group Insights (Revenue, USD Mn, 2021 - 2033)
- Adults
- Geriatric
- Pediatric and Adolescents
- Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
- Online
- Offline
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Medtronic
- Stryker
- Boston Scientific
- Becton Dickinson (BD)
- Zimmer Biomet
- Smith and Nephew
- Johnson and Johnson (DePuy Synthes)
- Philips Healthcare
- Siemens Healthineers
- GE HealthCare
- Mindray
- Canon Medical Systems
- Fujifilm Healthcare
- Terumo Corporation
- AngioDynamics
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Thoracic Outlet Syndrome Market, By Type
- Global Thoracic Outlet Syndrome Market, By Treatment Device Type
- Global Thoracic Outlet Syndrome Market, By Diagnosis Technology
- Global Thoracic Outlet Syndrome Market, By End User
- Global Thoracic Outlet Syndrome Market, By Patient Group
- Global Thoracic Outlet Syndrome Market, By Distribution Channel
- Global Thoracic Outlet Syndrome Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Thoracic Outlet Syndrome Market, By Type, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Neurogenic Thoracic Outlet Syndrome
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Venous Thoracic Outlet Syndrome
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Arterial Thoracic Outlet Syndrome
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Combined/Mixed TOS (neurogenic + vascular)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
5. Global Thoracic Outlet Syndrome Market, By Treatment Device Type, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Minimally Invasive Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Catheters (Diagnostic and Interventional)
- Thrombectomy Devices
- Angioplasty Balloons
- Vascular Stents
- Others (Thrombolytic Delivery Systems)
- Surgical Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Thoracoscopic Instruments (VATS Tools)
- Robotic-Assisted Surgical Systems
- Open Surgical Instruments (Resection Tools, Scalpels, Clamps)
- Others (Hemostatic and Sealing Devices)
- Supportive/Non-Surgical Treatment Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Orthopedic Braces and Postural Correction Devices
- Physiotherapy and Rehabilitation Devices
- Others (Neuromodulation and Pain Management Devices)
6. Global Thoracic Outlet Syndrome Market, By Diagnosis Technology, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Electrodiagnostic Systems (EMG and Nerve Conduction Devices)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Ultrasound Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- CT Scan and CT Angiography Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- MRI and MR Angiography Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- X-ray and Digital Radiography Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Vascular Doppler Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
7. Global Thoracic Outlet Syndrome Market, By End User, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Diagnostic Imaging Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Rehabilitation and Physiotherapy Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
8. Global Thoracic Outlet Syndrome Market, By Patient Group, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Pediatric and Adolescents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
9. Global Thoracic Outlet Syndrome Market, By Distribution Channel, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Online
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Offline
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
10. Global Thoracic Outlet Syndrome Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Treatment Device Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Diagnosis Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Patient Group, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Treatment Device Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Diagnosis Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Patient Group, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Treatment Device Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Diagnosis Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Patient Group, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Treatment Device Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Diagnosis Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Patient Group, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Treatment Device Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Diagnosis Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Patient Group, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Treatment Device Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Diagnosis Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Patient Group, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Medtronic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Stryker
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boston Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Becton Dickinson (BD)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Zimmer Biomet
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Smith and Nephew
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson and Johnson (DePuy Synthes)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Philips Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GE HealthCare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mindray
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Canon Medical Systems
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fujifilm Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Terumo Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AngioDynamics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
